866-997-4948(US-Canada Toll Free)

Global Anti-malarial Drugs Market Insights, Forecast to 2025

Published By :

QYResearch

Published Date : Sep 2018

Category :

Pharmaceutical

No. of Pages : 116 Pages

This report studies the global market size of Anti-malarial Drugs in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Anti-malarial Drugs in these regions.
This research report categorizes the global Anti-malarial Drugs market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter's Five Forces Analysis.

In 2017, the global Anti-malarial Drugs market size was million US$ and is forecast to million US in 2025, growing at a CAGR of from 2018. The objectives of this study are to define, segment, and project the size of the Anti-malarial Drugs market based on company, product type, application and key regions.

The various contributors involved in the value chain of Anti-malarial Drugs include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in the Anti-malarial Drugs include
Merck KGaA
F. Hoffmann-La Roche AG
Novartis AG
GlaxoSmithKline Plc
Ranbaxy Laboratories
Zydus Cadila
Alvizia Health Care
Bayer AG
Pfizer, Inc.
Ipca Laboratories Ltd

Market Size Split by Type
Quinine
Chloroquine
Pyrimethamine
Amodiaquine
Proguanil
Mefloquine
Sulfonamide
Other
Market Size Split by Application
Falciparum Malaria
Vivax Malaria
Others

Market size split by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Anti-malarial Drugs market size (value & volume) by company, key regions/countries, products and application, history data from 2013 to 2017, and forecast to 2025.
To understand the structure of Anti-malarial Drugs market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Anti-malarial Drugs manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Anti-malarial Drugs with respect to individual growth trends, future prospects, and their contribution to the total market.
To project the value and volume of Anti-malarial Drugs submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Anti-malarial Drugs are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025

This report includes the estimation of market size for value (million US$) and volume (MT). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Anti-malarial Drugs market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents

1 Study Coverage
1.1 Anti-malarial Drugs Product
1.2 Key Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Anti-malarial Drugs Market Size Growth Rate by Type
1.4.2 Quinine
1.4.3 Chloroquine
1.4.4 Pyrimethamine
1.4.5 Amodiaquine
1.4.6 Proguanil
1.4.7 Mefloquine
1.4.8 Sulfonamide
1.4.9 Other
1.5 Market by Application
1.5.1 Global Anti-malarial Drugs Market Size Growth Rate by Application
1.5.2 Falciparum Malaria
1.5.3 Vivax Malaria
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Anti-malarial Drugs Market Size
2.1.1 Global Anti-malarial Drugs Revenue 2016-2025
2.1.2 Global Anti-malarial Drugs Sales 2016-2025
2.2 Anti-malarial Drugs Growth Rate by Regions
2.2.1 Global Anti-malarial Drugs Sales by Regions
2.2.2 Global Anti-malarial Drugs Revenue by Regions

3 Breakdown Data by Manufacturers
3.1 Anti-malarial Drugs Sales by Manufacturers
3.1.1 Anti-malarial Drugs Sales by Manufacturers
3.1.2 Anti-malarial Drugs Sales Market Share by Manufacturers
3.1.3 Global Anti-malarial Drugs Market Concentration Ratio (CR5 and HHI)
3.2 Anti-malarial Drugs Revenue by Manufacturers
3.2.1 Anti-malarial Drugs Revenue by Manufacturers (2016-2018)
3.2.2 Anti-malarial Drugs Revenue Share by Manufacturers (2016-2018)
3.3 Anti-malarial Drugs Price by Manufacturers
3.4 Anti-malarial Drugs Manufacturing Base Distribution, Product Types
3.4.1 Anti-malarial Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Anti-malarial Drugs Product Category
3.4.3 Date of International Manufacturers Enter into Anti-malarial Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type
4.1 Global Anti-malarial Drugs Sales by Type
4.2 Global Anti-malarial Drugs Revenue by Type
4.3 Anti-malarial Drugs Price by Type

5 Breakdown Data by Application
5.1 Overview
5.2 Global Anti-malarial Drugs Breakdown Data by Application

6 North America
6.1 North America Anti-malarial Drugs by Countries
6.1.1 North America Anti-malarial Drugs Sales by Countries
6.1.2 North America Anti-malarial Drugs Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Anti-malarial Drugs by Type
6.3 North America Anti-malarial Drugs by Application
6.4 North America Anti-malarial Drugs by Company

7 Europe
7.1 Europe Anti-malarial Drugs by Countries
7.1.1 Europe Anti-malarial Drugs Sales by Countries
7.1.2 Europe Anti-malarial Drugs Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Anti-malarial Drugs by Type
7.3 Europe Anti-malarial Drugs by Application
7.4 Europe Anti-malarial Drugs by Company

8 Asia Pacific
8.1 Asia Pacific Anti-malarial Drugs by Countries
8.1.1 Asia Pacific Anti-malarial Drugs Sales by Countries
8.1.2 Asia Pacific Anti-malarial Drugs Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Anti-malarial Drugs by Type
8.3 Asia Pacific Anti-malarial Drugs by Application
8.4 Asia Pacific Anti-malarial Drugs by Company

9 Central & South America
9.1 Central & South America Anti-malarial Drugs by Countries
9.1.1 Central & South America Anti-malarial Drugs Sales by Countries
9.1.2 Central & South America Anti-malarial Drugs Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Anti-malarial Drugs by Type
9.3 Central & South America Anti-malarial Drugs by Application
9.4 Central & South America Anti-malarial Drugs by Company

10 Middle East and Africa
10.1 Middle East and Africa Anti-malarial Drugs by Countries
10.1.1 Middle East and Africa Anti-malarial Drugs Sales by Countries
10.1.2 Middle East and Africa Anti-malarial Drugs Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Anti-malarial Drugs by Type
10.3 Middle East and Africa Anti-malarial Drugs by Application
10.4 Middle East and Africa Anti-malarial Drugs by Company

11 Company Profiles
11.1 Merck KGaA
11.1.1 Merck KGaA Company Details
11.1.2 Company Description
11.1.3 Sales, Revenue and Gross Margin of Anti-malarial Drugs
11.1.4 Anti-malarial Drugs Product Description
11.1.5 Recent Development
11.2 F. Hoffmann-La Roche AG
11.2.1 F. Hoffmann-La Roche AG Company Details
11.2.2 Company Description
11.2.3 Sales, Revenue and Gross Margin of Anti-malarial Drugs
11.2.4 Anti-malarial Drugs Product Description
11.2.5 Recent Development
11.3 Novartis AG
11.3.1 Novartis AG Company Details
11.3.2 Company Description
11.3.3 Sales, Revenue and Gross Margin of Anti-malarial Drugs
11.3.4 Anti-malarial Drugs Product Description
11.3.5 Recent Development
11.4 GlaxoSmithKline Plc
11.4.1 GlaxoSmithKline Plc Company Details
11.4.2 Company Description
11.4.3 Sales, Revenue and Gross Margin of Anti-malarial Drugs
11.4.4 Anti-malarial Drugs Product Description
11.4.5 Recent Development
11.5 Ranbaxy Laboratories
11.5.1 Ranbaxy Laboratories Company Details
11.5.2 Company Description
11.5.3 Sales, Revenue and Gross Margin of Anti-malarial Drugs
11.5.4 Anti-malarial Drugs Product Description
11.5.5 Recent Development
11.6 Zydus Cadila
11.6.1 Zydus Cadila Company Details
11.6.2 Company Description
11.6.3 Sales, Revenue and Gross Margin of Anti-malarial Drugs
11.6.4 Anti-malarial Drugs Product Description
11.6.5 Recent Development
11.7 Alvizia Health Care
11.7.1 Alvizia Health Care Company Details
11.7.2 Company Description
11.7.3 Sales, Revenue and Gross Margin of Anti-malarial Drugs
11.7.4 Anti-malarial Drugs Product Description
11.7.5 Recent Development
11.8 Bayer AG
11.8.1 Bayer AG Company Details
11.8.2 Company Description
11.8.3 Sales, Revenue and Gross Margin of Anti-malarial Drugs
11.8.4 Anti-malarial Drugs Product Description
11.8.5 Recent Development
11.9 Pfizer, Inc.
11.9.1 Pfizer, Inc. Company Details
11.9.2 Company Description
11.9.3 Sales, Revenue and Gross Margin of Anti-malarial Drugs
11.9.4 Anti-malarial Drugs Product Description
11.9.5 Recent Development
11.10 Ipca Laboratories Ltd
11.10.1 Ipca Laboratories Ltd Company Details
11.10.2 Company Description
11.10.3 Sales, Revenue and Gross Margin of Anti-malarial Drugs
11.10.4 Anti-malarial Drugs Product Description
11.10.5 Recent Development

12 Market Opportunities, Challenges, Risks and Influences Factors Analysis
12.1 Market Opportunities and Drivers
12.2 Market Challenges
12.3 Market Risks/Restraints
12.4 Key World Economic Indicators

13 Value Chain and Sales Channels Analysis
13.1 Value Chain Analysis
13.1.1 Typical Suppliers of Key Anti-malarial Drugs Raw Material
13.1.2 Anti-malarial Drugs Customers
13.2 Sales Channels Analysis
13.2.1 Sales Channels Analysis
13.2.2 Distributors

14 Research Findings and Conclusion

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
15.3 Disclaimer

List of Table

List of Tables and Figures

Figure Picture of Anti-malarial Drugs
Figure Global Anti-malarial Drugs Production (MT) and CAGR (%) Comparison by Types (Product Category) (2013-2025)
Figure Global Anti-malarial Drugs Production Market Share by Types (Product Category) in 2017
Figure Quinine Product Picture
Table Major Manufacturers of Quinine
Figure Chloroquine Product Picture
Table Major Manufacturers of Chloroquine
Figure Pyrimethamine Product Picture
Table Major Manufacturers of Pyrimethamine
Figure Amodiaquine Product Picture
Table Major Manufacturers of Amodiaquine
Figure Proguanil Product Picture
Table Major Manufacturers of Proguanil
Figure Mefloquine Product Picture
Table Major Manufacturers of Mefloquine
Figure Sulfonamide Product Picture
Table Major Manufacturers of Sulfonamide
Figure Other Product Picture
Table Major Manufacturers of Other
Table Global Anti-malarial Drugs Market Size Growth Rate by Application 2018-2025 (MT)
Figure Falciparum Malaria
Figure Vivax Malaria
Figure Others
Figure Anti-malarial Drugs Report Years Considered
Figure Global Anti-malarial Drugs Market Size 2016-2025 (Million US$)
Figure Global Anti-malarial Drugs Sales 2016-2025 (MT)
Table Global Anti-malarial Drugs Market Size by Regions 2016-2025 (MT) & (Million US$)
Table Global Anti-malarial Drugs Sales by Regions 2016-2025 (MT)
Table Global Anti-malarial Drugs Sales Market Share by Regions 2016-2025
Figure Global Anti-malarial Drugs Sales Market Share by Regions 2016-2025
Figure 2017 Global Anti-malarial Drugs Sales Market Share by Regions
Table Global Anti-malarial Drugs Revenue by Regions 2016-2025 (Million US$)
Table Global Anti-malarial Drugs Revenue Market Share by Regions 2016-2025
Figure Global Anti-malarial Drugs Revenue Market Share by Regions 2016-2025
Figure 2017 Global Anti-malarial Drugs Revenue Market Share by Regions
Table Global Anti-malarial Drugs Sales by Manufacturers (2016-2018) (MT)
Table Global Anti-malarial Drugs Sales Share by Manufacturers (2016-2018)
Figure Global Anti-malarial Drugs Sales Share by Manufacturers in 2017
Table Anti-malarial Drugs Revenue by Manufacturers (2016-2018) (Million US$)
Table Anti-malarial Drugs Revenue Share by Manufacturers (2016-2018)
Figure Anti-malarial Drugs Value Share by Manufacturers in 2017
Table Global Anti-malarial Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Manufacturers Anti-malarial Drugs Price (2016-2018) (USD/Kg)
Table Anti-malarial Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Anti-malarial Drugs Product Category
Table Date of International Manufacturers Enter into Anti-malarial Drugs Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Anti-malarial Drugs Sales by Type (2016-2025) (MT)
Table Global Anti-malarial Drugs Sales Share by Type (2016-2025)
Figure Global Anti-malarial Drugs Sales Market Share by Type (2016-2025)
Figure Global Anti-malarial Drugs Sales Market Share by Type in 2017
Table Global Anti-malarial Drugs Revenue by Type (2016-2025) (Million US$)
Table Global Anti-malarial Drugs Revenue Share by Type (2016-2025)
Figure Global Anti-malarial Drugs Revenue Market Share by Type (2016-2025)
Figure Global Anti-malarial Drugs Revenue Market Share by Type in 2017
Table Anti-malarial Drugs Price by Type 2013-2018 (USD/Kg)
Table Global Anti-malarial Drugs Sales by Application (2016-2025) (MT)
Table Global Anti-malarial Drugs Sales Share by Application (2016-2025)
Figure Global Sales Anti-malarial Drugs Market Share by Application (2016-2025)
Figure Global Sales Anti-malarial Drugs Market Share by Application (2016-2025)
Figure North America Anti-malarial Drugs Sales Growth Rate 2016-2025 (MT)
Figure North America Anti-malarial Drugs Revenue Growth Rate 2016-2025 (Million US$)
Table North America Anti-malarial Drugs Sales by Countries (2016-2025) (MT)
Table North America Anti-malarial Drugs Sales Market Share by Countries (2016-2025)
Figure 2017 North America Anti-malarial Drugs Sales Market Share by Countries
Table North America Anti-malarial Drugs Revenue by Countries (2016-2025) (Million US$)
Table North America Anti-malarial Drugs Revenue Market Share by Countries (2016-2025)
Figure 2017 North America Anti-malarial Drugs Revenue Market Share by Countries
Figure United States Anti-malarial Drugs Sales Growth Rate (2016-2025) (MT)
Figure United States Anti-malarial Drugs Revenue Growth Rate (2016-2025) (Million US$)
Figure Canada Anti-malarial Drugs Sales Growth Rate (2016-2025) (MT)
Figure Canada Anti-malarial Drugs Revenue Growth Rate (2016-2025) (Million US$)
Figure Mexico Anti-malarial Drugs Sales Growth Rate (2016-2025) (MT)
Figure Mexico Anti-malarial Drugs Revenue Growth Rate (2016-2025) (Million US$)
Table North America Anti-malarial Drugs Sales by Type (2016-2025) (MT)
Table North America Anti-malarial Drugs Sales Market Share by Type (2016-2025)
Figure 2017 North America Anti-malarial Drugs Market Share by Type
Table North America Anti-malarial Drugs Sales by Application (2016-2025) (MT)
Table North America Anti-malarial Drugs Sales Market Share by Application (2016-2025)
Figure 2017 North America Anti-malarial Drugs Market Share by Application
Table North America Anti-malarial Drugs Sales by Company (2016-2018) (MT)
Table North America Anti-malarial Drugs Sales Market Share by Company (2016-2018)
Figure North America Anti-malarial Drugs Sales Market Share by Company in 2017
Figure Europe Anti-malarial Drugs Sales Growth Rate 2016-2025 (MT)
Figure Europe Anti-malarial Drugs Revenue Growth Rate 2016-2025 (Million US$)
Table Europe Anti-malarial Drugs Sales by Countries (2016-2025) (MT)
Table Europe Anti-malarial Drugs Sales Market Share by Countries (2016-2025)
Figure 2017 Europe Anti-malarial Drugs Sales Market Share by Countries
Table Europe Anti-malarial Drugs Revenue by Countries (2016-2025) (Million US$)
Table Europe Anti-malarial Drugs Revenue Market Share by Countries (2016-2025)
Figure 2017 Europe Anti-malarial Drugs Revenue Market Share by Countries
Figure Germany Anti-malarial Drugs Sales Growth Rate (2016-2025) (MT)
Figure Germany Anti-malarial Drugs Revenue Growth Rate (2016-2025) (MT)
Figure France Anti-malarial Drugs Sales Growth Rate (2016-2025) (MT)
Figure France Anti-malarial Drugs Revenue Growth Rate (2016-2025) (MT)
Figure UK Anti-malarial Drugs Sales Growth Rate (2016-2025) (MT)
Figure UK Anti-malarial Drugs Revenue Growth Rate (2016-2025) (Million US$)
Figure Italy Anti-malarial Drugs Sales Growth Rate (2016-2025) (MT)
Figure Italy Anti-malarial Drugs Revenue Growth Rate (2016-2025) (Million US$)
Figure Russia Anti-malarial Drugs Sales Growth Rate (2016-2025) (MT)
Figure Russia Anti-malarial Drugs Revenue Growth Rate (2016-2025) (Million US$)
Table Europe Anti-malarial Drugs Sales by Type (2016-2025) (MT)
Table Europe Anti-malarial Drugs Sales Market Share by Type (2016-2025)
Figure 2017 Europe Anti-malarial Drugs Market Share by Type
Table Europe Anti-malarial Drugs Sales by Application (2016-2025) (MT)
Table Europe Anti-malarial Drugs Sales Market Share by Application (2016-2025)
Figure 2017 Europe Anti-malarial Drugs Market Share by Application
Table Europe Anti-malarial Drugs Sales by Company (2016-2018) (MT)
Table Europe Anti-malarial Drugs Sales Market Share by Company (2016-2018)
Figure Europe Anti-malarial Drugs Sales Market Share by Company in 2017
Figure Asia Pacific Anti-malarial Drugs Sales Growth Rate 2016-2025 (MT)
Figure Asia Pacific Anti-malarial Drugs Revenue Growth Rate 2016-2025 (Million US$)
Table Asia Pacific Anti-malarial Drugs Sales by Countries (2016-2025) (MT)
Table Asia Pacific Anti-malarial Drugs Sales Market Share by Countries (2016-2025)
Figure 2017 Asia Pacific Anti-malarial Drugs Sales Market Share by Countries
Table Asia Pacific Anti-malarial Drugs Revenue by Countries (2016-2025) (Million US$)
Table Asia Pacific Anti-malarial Drugs Revenue Market Share by Countries (2016-2025)
Figure 2017 Asia Pacific Anti-malarial Drugs Revenue Market Share by Countries
Figure China Anti-malarial Drugs Sales Growth Rate (2016-2025) (MT)
Figure China Anti-malarial Drugs Revenue Growth Rate (2016-2025) (Million US$)
Figure Japan Anti-malarial Drugs Sales Growth Rate (2016-2025) (MT)
Figure Japan Anti-malarial Drugs Revenue Growth Rate (2016-2025) (Million US$)
Figure Korea Anti-malarial Drugs Sales Growth Rate (2016-2025) (MT)
Figure Korea Anti-malarial Drugs Revenue Growth Rate (2016-2025) (Million US$)
Figure India Anti-malarial Drugs Sales Growth Rate (2016-2025) (MT)
Figure India Anti-malarial Drugs Revenue Growth Rate (2016-2025) (Million US$)
Figure Australia Anti-malarial Drugs Sales Growth Rate (2016-2025) (MT)
Figure Australia Anti-malarial Drugs Revenue Growth Rate (2016-2025) (Million US$)
Figure Indonesia Anti-malarial Drugs Sales Growth Rate (2016-2025) (MT)
Figure Indonesia Anti-malarial Drugs Revenue Growth Rate (2016-2025) (Million US$)
Figure Malaysia Anti-malarial Drugs Sales Growth Rate (2016-2025) (MT)
Figure Malaysia Anti-malarial Drugs Revenue Growth Rate (2016-2025) (Million US$)
Figure Philippines Anti-malarial Drugs Sales Growth Rate (2016-2025) (MT)
Figure Philippines Anti-malarial Drugs Revenue Growth Rate (2016-2025) (Million US$)
Figure Thailand Anti-malarial Drugs Sales Growth Rate (2016-2025) (MT)
Figure Thailand Anti-malarial Drugs Revenue Growth Rate (2016-2025) (Million US$)
Figure Vietnam Anti-malarial Drugs Sales Growth Rate (2016-2025) (MT)
Figure Vietnam Anti-malarial Drugs Revenue Growth Rate (2016-2025) (Million US$)
Figure Singapore Anti-malarial Drugs Sales Growth Rate (2016-2025) (MT)
Figure Singapore Anti-malarial Drugs Revenue Growth Rate (2016-2025) (Million US$)
Table Asia Pacific Anti-malarial Drugs Sales by Type (2016-2025) (MT)
Table Asia Pacific Anti-malarial Drugs Sales Market Share by Type (2016-2025)
Figure 2017 Asia Pacific Anti-malarial Drugs Market Share by Type
Table Asia Pacific Anti-malarial Drugs Sales by Application (2016-2025) (MT)
Table Asia Pacific Anti-malarial Drugs Sales Market Share by Application (2016-2025)
Figure 2017 Asia Pacific Anti-malarial Drugs Market Share by Application
Table Asia Pacific Anti-malarial Drugs Sales by Company (2016-2018) (MT)
Table Asia Pacific Anti-malarial Drugs Sales Market Share by Company (2016-2018)
Figure Asia Pacific Anti-malarial Drugs Sales Market Share by Company in 2017
Figure Central & South America Anti-malarial Drugs Sales Growth Rate 2016-2025 (MT)
Figure Central & South America Anti-malarial Drugs Revenue Growth Rate 2016-2025 (Million US$)
Table Central & South America Anti-malarial Drugs Sales by Countries (2016-2025) (MT)
Table Central & South America Anti-malarial Drugs Sales Market Share by Countries (2016-2025)
Figure 2017 Central & South America Anti-malarial Drugs Sales Market Share by Countries
Table Central & South America Anti-malarial Drugs Revenue by Countries (2016-2025) (Million US$)
Table Central & South America Anti-malarial Drugs Revenue Market Share by Countries (2016-2025)
Figure 2017 Central & South America Anti-malarial Drugs Revenue Market Share by Countries
Figure Brazil Anti-malarial Drugs Sales Growth Rate (2016-2025) (MT)
Figure Brazil Anti-malarial Drugs Revenue Growth Rate (2016-2025) (Million US$)
Figure Argentina Anti-malarial Drugs Sales Growth Rate (2016-2025) (MT)
Figure Argentina Anti-malarial Drugs Revenue Growth Rate (2016-2025) (Million US$)
Table Central & South America Anti-malarial Drugs Sales by Type (2016-2025) (MT)
Table Central & South America Anti-malarial Drugs Sales Market Share by Type (2016-2025)
Figure 2017 Central & South America Anti-malarial Drugs Market Share by Type
Table Central & South America Anti-malarial Drugs Sales by Application (2016-2025) (MT)
Table Central & South America Anti-malarial Drugs Sales Market Share by Application (2016-2025)
Figure 2017 Central & South America Anti-malarial Drugs Market Share by Application
Table Central & South America Anti-malarial Drugs Sales by Company (2016-2018) (MT)
Table Central & South America Anti-malarial Drugs Sales Market Share by Company (2016-2018)
Figure Central & South America Anti-malarial Drugs Sales Market Share by Company in 2017
Figure Middle East and Africa Anti-malarial Drugs Sales Growth Rate 2016-2025 (MT)
Figure Middle East and Africa Anti-malarial Drugs Revenue Growth Rate 2016-2025 (Million US$)
Table Middle East and Africa Anti-malarial Drugs Sales by Countries (2016-2025) (MT)
Table Middle East and Africa Anti-malarial Drugs Sales Market Share by Countries (2016-2025)
Figure 2017 Middle East and Africa Anti-malarial Drugs Sales Market Share by Countries
Table Middle East and Africa Anti-malarial Drugs Revenue by Countries (2016-2025) (Million US$)
Table Middle East and Africa Anti-malarial Drugs Revenue Market Share by Countries (2016-2025)
Figure 2017 Middle East and Africa Anti-malarial Drugs Revenue Market Share by Countries
Figure GCC Countries Anti-malarial Drugs Sales Growth Rate (2016-2025) (MT)
Figure GCC Countries Anti-malarial Drugs Revenue Growth Rate (2016-2025) (Million US$)
Figure Turkey Anti-malarial Drugs Sales Growth Rate (2016-2025) (MT)
Figure Turkey Anti-malarial Drugs Revenue Growth Rate (2016-2025) (Million US$)
Figure Egypt Anti-malarial Drugs Sales Growth Rate (2016-2025) (MT)
Figure Egypt Anti-malarial Drugs Revenue Growth Rate (2016-2025) (Million US$)
Figure South Africa Anti-malarial Drugs Sales Growth Rate (2016-2025) (MT)
Figure South Africa Anti-malarial Drugs Revenue Growth Rate (2016-2025) (Million US$)
Table Middle East and Africa Anti-malarial Drugs Sales by Type (2016-2025) (MT)
Table Middle East and Africa Anti-malarial Drugs Sales Market Share by Type (2016-2025)
Figure 2017 Middle East and Africa Anti-malarial Drugs Market Share by Type
Table Middle East and Africa Anti-malarial Drugs Sales by Application (2016-2025) (MT)
Table Middle East and Africa Anti-malarial Drugs Sales Market Share by Application (2016-2025)
Figure 2017 Middle East and Africa Anti-malarial Drugs Market Share by Application
Table Middle East and Africa Anti-malarial Drugs Sales by Company (2016-2018) (MT)
Table Middle East and Africa Anti-malarial Drugs Sales Market Share by Company (2016-2018)
Figure Middle East and Africa Anti-malarial Drugs Sales Market Share by Company in 2017
Table Merck KGaA Company Details
Table Merck KGaA Anti-malarial Drugs Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2018)
Table Merck KGaA Recent Development
Table F. Hoffmann-La Roche AG Company Details
Table F. Hoffmann-La Roche AG Anti-malarial Drugs Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2018)
Table F. Hoffmann-La Roche AG Recent Development
Table Novartis AG Company Details
Table Novartis AG Anti-malarial Drugs Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2018)
Table Novartis AG Recent Development
Table GlaxoSmithKline Plc Company Details
Table GlaxoSmithKline Plc Anti-malarial Drugs Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2018)
Table GlaxoSmithKline Plc Recent Development
Table Ranbaxy Laboratories Company Details
Table Ranbaxy Laboratories Anti-malarial Drugs Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2018)
Table Ranbaxy Laboratories Recent Development
Table Zydus Cadila Company Details
Table Zydus Cadila Anti-malarial Drugs Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2018)
Table Zydus Cadila Recent Development
Table Alvizia Health Care Company Details
Table Alvizia Health Care Anti-malarial Drugs Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2018)
Table Alvizia Health Care Recent Development
Table Bayer AG Company Details
Table Bayer AG Anti-malarial Drugs Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2018)
Table Bayer AG Recent Development
Table Pfizer, Inc. Company Details
Table Pfizer, Inc. Anti-malarial Drugs Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2018)
Table Pfizer, Inc. Recent Development
Table Ipca Laboratories Ltd Company Details
Table Ipca Laboratories Ltd Anti-malarial Drugs Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2018)
Table Ipca Laboratories Ltd Recent Development
Figure GDP by Regions / Largest Economies Pie Chart in 2016
Figure G20 GDP Long-Term Forecast Total, Million US dollars, 2060
Figure G20 Gross Domestic Product (GDP)Total, US Dollars/Capita, 2016
Figure Saving Rate Total, % of GDP, 2015
Table Anti-malarial Drugs Value Chain
Table Typical Suppliers of Key Anti-malarial Drugs Raw Material
Table Anti-malarial Drugs Customers List
Table Anti-malarial Drugs Sales Channels
Table Anti-malarial Drugs Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *